HARD ITERATION CAP: 5 per document. This is iter 3 of 5.
- Reserve P0/P1 for real execution risks; nits are P2/P3.
- Verdict APPROVE iff zero NOVEL P0 AND zero P1.

FOCUSED RE-REVIEW. History: iter-1 = 2 P1s; iter-2 = P1-1 (BUG-19) RESOLVED, 1 CONTINUING P1 — `_generic_drug_signal` (completeness_checker.py) could be tripped by non-drug terms (administered / subcutaneous / intramuscular / dosing → "self-administered questionnaire", "subcutaneous fat", "radiation dosing"), which in the critical confident-negative branch returns applies=True and could SPURIOUSLY HOLD a non-drug report via abort_critical_topic_uncovered. THIS iter reviews ONLY the fix for that continuing P1. STATIC review only.

READ: `.codex/I-arch-006/p1_fix_iter3.diff` (26 lines). The fix REMOVES `administered`, `intravenous*`, `subcutaneous*`, `intramuscular*`, `dosage`, `dosing` from `_GENERIC_DRUG_SIGNAL_RE`, keeping ONLY unambiguous drug-identity/class/form/dose-unit terms: drugs?/medications?/pharmacotherap*/pharmacolog*/pharmacokinetic*/pharmacodynamic*/posology/milligrams?/micrograms?/tablets?/capsules?/inhibitors?/agonists?/antagonists?/monoclonal/chemotherap*/antibiotics?/antiviral* and `\d+ mg` / `mg/kg|day|dl`.

VERIFY:
1. Can a NON-drug question still trip `_generic_drug_signal` via any REMAINING term and spuriously fail-closed (hold) a non-drug report? (Consider the 3 golden non-drug Qs: gut-microbiota/CRC, Parkinson's-DBS, metal-ions/CVD, plus the iter-2 examples.)
2. Is the fail-closed safety net still PRESERVED for a real drug question whose specific brand the recognizer missed (such a question still carries a drug-class/form/mg term)?
3. Any NOVEL P0/P1 introduced by THIS 26-line delta only?

OUTPUT EXACTLY:
verdict: APPROVE | REQUEST_CHANGES
novel_p0: [...]
continuing_p0: [...]
p1: [...]
p2: [...]
convergence_call: continue | accept_remaining
remaining_blockers_for_execution: [...]

APPROVE iff the continuing P1 is resolved and this delta introduces zero new P0/P1.
